Abstract: Methods of treating B2-bradykinin receptor mediated angioedema in a subject by administering a composition containing a 8-(heteroarylmethoxy)quinolone compound, a 8-(arylmethoxy)quinoline compound, or a salt, a stereoisomer, a hydrate, or a solvate thereof. Oral formulations containing a 8-(heteroarylmethoxy)quinolone compound, a 8-(arylmethoxy)quinoline compound, or a salt, a stereoisomer, a hydrate, or a solvate thereof for the treatment of B2-bradykinin receptor mediated angioedema. Use of a composition containing a 8-(heteroarylmethoxy)quinolone compound, a 8-(arylmethoxy)quinoline compound, or a salt, a stereoisomer, a hydrate, or a solvate thereof for the manufacture of a medicament for the treatment and/or prevention of a B2-bradykinin receptor mediated angioedema.

Abstract: A method for use in an interactive system includes receiving position information for a controller that is being manipulated by a user, analyzing the received position information to determine whether a predetermined movement of the controller has been performed, and changing the user's viewpoint of a scene displayed on a display in response to the predetermined movement of the controller being performed. Another embodiment provides a method for use in an interactive system that includes moving at least a portion of a character in a scene displayed on a display in response to the predetermined movement of the controller being performed.